Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 397

1.

Novel potential for the management of Alzheimer disease.

Ginter E, Simko V, Weinrebova D, Ladecka Z.

Bratisl Lek Listy. 2015;116(10):580-1. Review.

PMID:
26531866
2.

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.

Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P.

J Alzheimers Dis. 2015;48(4):891-917. doi: 10.3233/JAD-150379. Review.

PMID:
26444774
3.

Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions.

Bhat NR.

J Alzheimers Dis. 2015;46(3):581-91. doi: 10.3233/JAD-150098. Review.

4.

Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline.

Walker JM, Harrison FE.

Nutrients. 2015 Sep 1;7(9):7332-57. doi: 10.3390/nu7095341. Review.

5.

Linking insulin with Alzheimer's disease: emergence as type III diabetes.

Ahmed S, Mahmood Z, Zahid S.

Neurol Sci. 2015 Oct;36(10):1763-9. doi: 10.1007/s10072-015-2352-5. Epub 2015 Aug 7. Review.

PMID:
26248483
6.

[Angiotensin converting enzyme: the antigenic properties of the domain, role in Alzheimer's disease and tumor progression].

Kugaevskaya EV, Timoshenko OS, Solovyeva NI.

Biomed Khim. 2015 May-Jun;61(3):301-11. doi: 10.18097/PBMC20156103301. Review. Russian.

PMID:
26215407
7.

Proton myo-inositol cotransporter is a novel γ-secretase associated protein that regulates Aβ production without affecting Notch cleavage.

Teranishi Y, Inoue M, Yamamoto NG, Kihara T, Wiehager B, Ishikawa T, Winblad B, Schedin-Weiss S, Frykman S, Tjernberg LO.

FEBS J. 2015 Sep;282(17):3438-51. doi: 10.1111/febs.13353. Epub 2015 Jul 14. Review.

PMID:
26094765
8.

Regulation of TRPML1 function.

Waller-Evans H, Lloyd-Evans E.

Biochem Soc Trans. 2015 Jun;43(3):442-6. doi: 10.1042/BST20140311. Review.

PMID:
26009188
9.

Rivastigmine for Alzheimer's disease.

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3. Review.

PMID:
25858345
10.

Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.

Li X, Song D, Leng SX.

Clin Interv Aging. 2015 Mar 10;10:549-60. doi: 10.2147/CIA.S74042. eCollection 2015. Review.

11.

Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.

Wang JZ, Wang ZH.

Exp Gerontol. 2015 Aug;68:82-6. doi: 10.1016/j.exger.2015.03.007. Epub 2015 Mar 14. Review.

PMID:
25777063
12.

Angiotensin and neurovascular coupling: beyond hypertension.

Bloch S, Obari D, Girouard H.

Microcirculation. 2015 Apr;22(3):159-67. doi: 10.1111/micc.12193. Review.

PMID:
25660297
13.

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease.

Casamenti F, Grossi C, Rigacci S, Pantano D, Luccarini I, Stefani M.

J Alzheimers Dis. 2015;45(3):679-88. doi: 10.3233/JAD-142850. Review.

PMID:
25649656
14.

Disturbed mitochondrial dynamics and neurodegenerative disorders.

Burté F, Carelli V, Chinnery PF, Yu-Wai-Man P.

Nat Rev Neurol. 2015 Jan;11(1):11-24. doi: 10.1038/nrneurol.2014.228. Epub 2014 Dec 9. Review.

PMID:
25486875
15.

Complementary roles of the neuron-enriched endosomal proteins NEEP21 and calcyon in neuronal vesicle trafficking.

Muthusamy N, Chen YJ, Yin DM, Mei L, Bergson C.

J Neurochem. 2015 Jan;132(1):20-31. doi: 10.1111/jnc.12989. Review.

16.

[Depression in the elderly: prodroma or risk factor for dementia? A critical review of the literature].

Bazin N, Bratu L.

Geriatr Psychol Neuropsychiatr Vieil. 2014 Sep;12(3):289-97. doi: 10.1684/pnv.2014.0490. Review. French.

PMID:
25245315
17.

Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

de la Monte SM.

Eur Neuropsychopharmacol. 2014 Dec;24(12):1954-60. doi: 10.1016/j.euroneuro.2014.06.008. Epub 2014 Jun 28. Review.

18.

(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, Feng J.

Cochrane Database Syst Rev. 2014 Jul 23;(7):CD010386. doi: 10.1002/14651858.CD010386.pub2. Review.

PMID:
25052054
19.

Matrix metalloproteinases and their multiple roles in Alzheimer's disease.

Wang XX, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:908636. doi: 10.1155/2014/908636. Epub 2014 Jun 24. Review.

20.

Prevalence and trends of dementia in Korea: a systematic review and meta-analysis.

Kim YJ, Han JW, So YS, Seo JY, Kim KY, Kim KW.

J Korean Med Sci. 2014 Jul;29(7):903-12. doi: 10.3346/jkms.2014.29.7.903. Epub 2014 Jul 11. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk